InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Wheadon David E., Director. Director active across 3 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 5 reports have been logged. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
010,430 shares0
Common Stock
SEC:0001789507-26-000008·
010,430 shares0
Common Stock
SEC:0001789507-26-000008:0·
010,643 shares0
Common Stock, $0.01 par value per share ("Common Stock")
SEC:0001822479-22-000038:0·
09,336 shares0
Common Stock, $0.01 par value per share ("Common Stock")
SEC:0001822479-21-000044·
09,336 shares0
Common Stock, $0.01 par value per share ("Common Stock")
SEC:0001822479-21-000044:0·
5 of 5 declarations
About Wheadon David E.
David E. Wheadon is a Board Member at Indivior Pharmaceuticals, Inc. and Sotera Health Co. He brings expertise in corporate governance and strategy. His role on the board is essential in guiding the strategic decisions of the companies.
